EXCLUSIVE- CHINA IS IN TALKS WITH PFIZER INC FOR LICENCE TO MANUFACTURE AND DISTRIBUTE A GENERIC VERSION OF THE U.S. FIRM'S COVID-19 ANTIVIRAL DRUG PAXLOVID IN CHINA -SOURCES
China Is In Talks With Pfizer Inc For Licence To Manu…
![Reuters logo](/images/reuters.jpg)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.83 USD | -1.38% |
|
-1.87% | -3.33% |
EXCLUSIVE- CHINA IS IN TALKS WITH PFIZER INC FOR LICENCE TO MANUFACTURE AND DISTRIBUTE A GENERIC VERSION OF THE U.S. FIRM'S COVID-19 ANTIVIRAL DRUG PAXLOVID IN CHINA -SOURCES
1st Jan change | Capi. | |
---|---|---|
-3.33% | 160B | |
+55.55% | 823B | |
+42.31% | 641B | |
-6.83% | 352B | |
+17.15% | 324B | |
+7.09% | 301B | |
+14.02% | 241B | |
+1.64% | 223B | |
+13.66% | 218B | |
+7.87% | 167B |